DENVER--(BUSINESS WIRE)--Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, a patent-pending dietary supplement that increases the body’s natural antioxidant defenses, today announced the appointment of Larry Gold, Ph.D. to its Board of Directors. Dr. Gold has served on the Lifeline Therapeutics Scientific Advisory Board since February 2006 and will now serve in both positions.
